Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights


Establishing a suspension culture-based lentiviral vector bioprocessing facility

Gabrielle Humphrey


GABRIELLE HUMPHREY, Associate Director is the lead of the Vector Manufacturing Science and Technology group at Adaptimmune, UK. In 2018, Gabrielle established the team responsible for starting-up Adaptimmune’s manufacturing capabilities at the Catapult CGT Manufacturing Centre in Stevenage. Her focus is currently on the production of GMP lentiviral vector for TCR T-cell therapy. Previously she has been involved in the GMP manufacturing of lentiviral vectors for CAR T-cell therapy and for gene therapy applications. Her area of expertise is the design and delivery of cleanroom bioprocesses for novel breakthrough therapies focusing on single-use disposable flow paths, aseptic processing and data monitoring.

DOI: 10.18609/cgti.2020.013
Citation: Cell & Gene Therapy Insights 2020; 6(1), 103-108.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog